AdamJButler (@AdamJButler) header
AdamJButler (@AdamJButler) profile picture

We can make clinical research better for everyone!

Philadelphia, PA, USA
Joined June 2011
Amy Abernathy at @CNSSummit “we need to make sure these technologies work for site coordinators.” Coordinators are the true workhorses of clinical trials!
1
1
3
Replying to @bijans
There are only 13 active recruitment sites in the US for patients who had COVID more than one month ago, all of them are giant academic centers.
2
What a blockbuster from @bddol - FDA leadership overrode an internal review to grant Apple’s Afib device a de novo exitsandoutcomes.com/who-con…
1
1
7
When the FDA COA office rejected Verily's VME, they specified finger-tapping as not meaningful. In this paper just published by FDA CDRH, they use finger-tapping as an example of a possible digital biomarker. nature.com/articles/s41746-0…
1
1
Really interesting paper from Verily on a fully remote observational study of patients with depression. One important finding - incentive payments to increase engagement only worked on healthy controls! mental.jmir.org/2021/8/e2758…
In 2020, planned enrollment in Alzheimer's trials was already at an all-time high. When Biogen rolls out a post-marketing study requiring thousands more trial participants, study enrichment will be stretched to the breaking point.
1
The 6MWT is not a great endpoint and these study results for a rare disease population are really good. The FDA should definitely approve this! endpts.com/rare-disease-drug…
I have learned that one really good way to keep up with new “digital biomarkers” is to click on every Instagram ad - my stories are full of stuff like this
1
Replying to @NedPagliarulo
This is a very interesting analysis!
This is total patient enrollment by year for all industry-funded Phase 2 and 3 Alzheimer's Disease intervention trials since 2011. There has been a huge surge in demand for patients to enroll in these trials. Aduhelm impact on US trial recruitment will be huge!
We’ve seen lots of innovation in clinical research the last few years that aims to use EHR data sources to increase trial recruitment or generate algorithms. The reality is that did data is often not really useful. statnews.com/2021/06/21/epic…
Replying to @BrianSkorney
CDR-SB was stat sig in EXPEDITION 3 (but not the primary) 🙃
1
These started showing up all over Philly during the pandemic - the bleakest form of telehealth/Medicare scam
A federal government watchdog is sounding the alarm that Americans’ growing enthusiasm for telehealth services during the coronavirus pandemic has led to a worrying parallel: a “dramatic increase” in telehealth-related fraud.  buff.ly/3brzNFj
Today I learned farts can be digital biomarkers statnews.com/2021/02/03/appl…
2
1
A fascinating finding in this @Sagebio/@Novartis paper on their elevateMS smartphone app "The local temperature elevations at the time of test completion negatively impacted participant’s performance" mhealth.jmir.org/2020/10/e22…
1
1
1
Placebo response in psychiatry and neurology is frequently attributable to trial design, execution, or site-related factors. This excellent paper on how errant clinical ratings impacted the Roche bitopertin schizophrenia trials should be very sobering! academic.oup.com/schizbullop…
1
I'm going to cite this paper next time someone asks me what "patient-centric" means. pubmed.ncbi.nlm.nih.gov/1876…
1
1
A few interesting things in the Moderna protocol, including this footnote about the "Oversight Group" that can over-ride the DSMB modernatx.com/sites/default/…